Curevo

As of 14 Oct 2026, Curevo has raised $110M across 1 verified round on record; latest: $110 million Series B led by Medicxi, announced 17 Mar 2025.

Curevo Inc. develops an adjuvanted subunit vaccine for the prevention of shingles in adults.

LATEST ROUND

Series B

$110M · 2025-03-17

RAISED ON RECORD · USD

$110M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Company

Every round on record, with the sources behind each and the investors on them.

Series B

$110M · 2025-03-17

[ HISTORY ]

Round	Amount	Announced	Lead	Buzz
Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$110M	2025-03-17	Medicxi	No recent discussion
1 source [ VERIFIED · CORRECTED ] read against 1 source HQ added near Seattle · globenewswire.com